Dmitry Balyasny’s KALA BIO KALA Stock Holding History

Dmitry Balyasny’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6	Closed	-$233K	–	1961
2018 Q1	$233K	Buy	6 +2	+50%	+$75.9K	﹤0.01%	1712
2017 Q4	$206K	Buy	+4	New	+$187K	﹤0.01%	1895

Other funds holding KALA

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dmitry Balyasny's KALA Position: Q2 2018 in Review

Dmitry Balyasny sold out of KALA BIO (KALA) in Q2 2018, closing a stake of 6 shares — an estimated $233K sold.

Dmitry Balyasny first reported a position in KALA in Q4 2017 and held it in 2 quarters. The position peaked at $233K in Q1 2018. 54 funds tracked by Wall St. Rank hold KALA as of Q2 2018.

Dmitry Balyasny reported no remaining KALA BIO position as of Q2 2018 after selling out during the quarter.
Dmitry Balyasny sold 6 KALA BIO shares in Q2 2018, an estimated $233K.
Dmitry Balyasny first reported a position in KALA BIO in Q4 2017 and held it in 2 quarters.
Dmitry Balyasny's KALA BIO position peaked at $233K in Q1 2018.
54 funds tracked by Wall St. Rank held KALA BIO as of Q2 2018.

Based on Balyasny Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.